KARYOPHARM THERAPEUTICS INC filings

SEC filings by KARYOPHARM THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2022-02-11Chione LtdKaryopharm Therapeutics Inc.5,000,0006.6%EDGAR
SC 13G2022-01-27BlackRock Inc.Karyopharm Therapeutics Inc.8,918,20611.8%EDGAR
SC 13G/A2022-01-26BlackRock Inc.Karyopharm Therapeutics Inc.8,918,20611.8%EDGAR
SC 13G/A2021-10-12STATE STREET CORPKaryopharm Therapeutics Inc.-10.6%EDGAR
SC 13G/A2021-02-17Consonance Capital Management LPKaryopharm Therapeutics Inc.00.0%EDGAR
SC 13G/A2021-02-16Consonance Capital Management LPKaryopharm Therapeutics Inc.00.0%EDGAR
SC 13G/A2021-02-16Kauffman MichaelKaryopharm Therapeutics Inc.4,231,4575.5%EDGAR
SC 13G/A2021-02-16Chione LtdKaryopharm Therapeutics Inc.5,500,0007.5%EDGAR
SC 13G/A2021-02-16Palo Alto Investors LPKaryopharm Therapeutics Inc.5,267,6527.2%EDGAR
SC 13G/A2021-02-12Avoro Capital Advisors LLCKaryopharm Therapeutics Inc.00.0%EDGAR
SC 13G/A2021-02-11ADAGE CAPITAL PARTNERS GP, L.L.C.Karyopharm Therapeutics Inc.2,465,0003.4%EDGAR
SC 13G2021-02-11STATE STREET CORPKaryopharm Therapeutics Inc.-7.3%EDGAR
SC 13G/A2021-01-27BlackRock Inc.Karyopharm Therapeutics Inc.7,475,09910.2%EDGAR
SC 13G2020-12-08BlackRock Inc.Karyopharm Therapeutics Inc.7,413,80510.1%EDGAR
SC 13G/A2020-02-14Point72 Asset Management, L.P.Karyopharm Therapeutics Inc.00.0%EDGAR
SC 13G/A2020-02-14Consonance Capital Management LPKaryopharm Therapeutics Inc.5,521,2478.8%EDGAR
SC 13G/A2020-02-14Ridgeback Capital Investments L.P.Karyopharm Therapeutics Inc.-0.0%EDGAR
SC 13G/A2020-02-14Chione LtdKaryopharm Therapeutics Inc.5,695,4999.1%EDGAR
SC 13G/A2020-02-14Palo Alto Investors LPKaryopharm Therapeutics Inc.4,595,0017.3%EDGAR
SC 13G2020-02-14Avoro Capital Advisors LLCKaryopharm Therapeutics Inc.5,900,0009.4%EDGAR